Moleculin Biotech, Inc. (MBRX)
NASDAQ·Healthcare·Biotechnology
$2.64
-2.22%
Mkt Cap $2.62M
No analyst coverage available
We don't have analyst ratings or price target data for Moleculin Biotech, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.